Add to a list

Inactive Instrument

Encision Inc. Share Price Other OTC

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	2.19M 1.9M 1.78M 1.63M 3.08M 209M 3.12M 20.86M 8.19M 104M 8.24M 8.06M 348M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.82M 2.64M 2.42M 4.56M 310M 4.62M 30.91M 12.13M 155M 12.21M 11.94M 515M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	38.58%	Yield 2024 *	-	Yield 2025	-

12-12	Encision Inc. Announces Management Changes	CI
12-12	Encision Inc. Announces CEO Changes	CI
11-13	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-03	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
18/08/25	Encision Inc. announced that it has received $0.5 million in funding	CI
15/08/25	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
10/07/25	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
14/02/25	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/11/24	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
14/11/24	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
14/08/24	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/07/24	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/07/24	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

07-16	Encision : Announces Start of Stock Trading	PU
07-14	Encision Inc. Announces Start of Stock Trading	AQ
05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
01-29	Encision : Announces Decision to Deregister its Common Stock	PU

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	07/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	31/07/2024
Denise Baker LAW	General Counsel	-	31/12/2018

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	31/12/1990
Robert Fries BRD	Director/Board Member	77	16/04/2024

Encision Inc. Share Price Other OTC

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Managers and Directors: Encision Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	-5.88%	-7.25%	-	-	849K
ABBOTT LABORATORIES	+2.13%	+2.23%	-17.54%	+0.29%	187B
MEDTRONIC PLC	-0.08%	+0.25%	-3.85%	+2.24%	110B
CENCORA, INC.	+2.46%	+4.09%	+14.53%	+75.37%	62.02B
HOYA CORPORATION	-0.18%	+3.20%	+36.14%	+52.39%	53.79B
BECTON, DICKINSON AND COMPANY	+3.76%	+7.02%	+2.70%	-34.61%	48.79B
MEDLINE INC.	-5.88%	-11.78%	-	-	30.27B
DEXCOM, INC.	+0.44%	+11.38%	+8.66%	-31.01%	31.33B
WEST PHARMACEUTICAL SERVICES, INC.	-0.69%	+2.65%	+46.92%	-7.06%	24.53B
STERIS PLC	-0.40%	+0.25%	+4.78%	+2.55%	22.59B
Average	-0.42%	+2.66%	+11.54%	+7.52%	63.35B
Weighted average by Cap.	+0.93%	+2.75%	+1.49%	+9.29%

	2024	2025
Net sales	6.59M 5.72M 5.35M 4.9M 9.24M 627M 9.36M 62.61M 24.57M 313M 24.73M 24.19M 1.04B	6.56M 5.69M 5.33M 4.87M 9.2M 624M 9.32M 62.32M 24.46M 312M 24.61M 24.08M 1.04B
Net income	-692K -600K -562K -514K -971K -65.9M -983K -6.58M -2.58M -32.92M -2.6M -2.54M -110M	-220K -191K -179K -164K -309K -20.98M -313K -2.09M -822K -10.48M -827K -809K -34.88M
Net Debt	1.29M 1.12M 1.05M 959K 1.81M 123M 1.83M 12.27M 4.82M 61.43M 4.85M 4.74M 204M	1.06M 917K 859K 785K 1.48M 101M 1.5M 10.05M 3.94M 50.29M 3.97M 3.88M 167M